TEPEZZA Short-Term Supply Disruption FAQ
Click here for a PDF version.
On December 17, 2020, Horizon announced that it expects a short-term disruption in TEPEZZA supply. Horizon shipped all of its remaining supply to sites of care (e.g., infusion centers, hospitals) at the end of December and TEPEZZA will not be available for patient use beginning in early January. We expect TEPEZZA will continue to be unavailable through the first quarter of 2021.2. What is the cause of this disruption?
This disruption is a result of recent COVID-19 vaccine production orders required by the government. This has dramatically restricted production capacity in terms of the number of manufacturing slots per month at the manufacturing facility that produces TEPEZZA. Of note, Horizon works with a separate company – sometimes called a “contract manufacturer” – to complete the last step in the manufacturing process for TEPEZZA. It is very common for biotech companies to work with an outside company to complete this step. Some of the companies that manufacture COVID-19 vaccine and therapeutics use the same contract manufacturer as Horizon. In order to increase capacity for vaccine production, the government has required that Horizon’s previously contracted TEPEZZA drug product manufacturing slots be canceled and provided to other companies to increase vaccine production. Because of this, TEPEZZA manufacturing slots have been significantly reduced and therefore our ability to produce enough TEPEZZA to meet patient demand has been disrupted.3. Was it Horizon’s decision to stop manufacturing TEPEZZA in order to increase vaccine production?
No, this was not Horizon’s decision. The decision was made by the government, through authority granted by invoking the Defense Production Act of 1950 related to manufacturing. We have had ongoing open dialogue with the U.S. Food and Drug Administration (FDA) and other government agencies to work through potential solutions, as well as elevate the significant burden of TED on patients and the importance of TEPEZZA to people who have been prescribed the medicine by their doctors. We will continue to do all that we can to end the short-term disruption in supply.4. Does Horizon make a COVID-19 vaccine?
No, Horizon does not make a COVID-19 vaccine. The partner contract manufacturing company that we use to manufacture TEPEZZA is the same partner company that other biotech companies use to manufacture COVID-19 vaccine and therapeutics.5. What is Horizon doing to end the TEPEZZA disruption?
Due to losing manufacturing space, Horizon now has fewer manufacturing slots at its contract manufacturer for TEPEZZA. We have one manufacturing slot where we used to have several per month (a slot is a dedicated space for production of a medicine). Horizon has submitted a prior approval supplement to the FDA to support more product output with each manufacturing slot than is currently approved by the FDA. Horizon is working closely with the FDA to expedite the review of the supplement, which is an important step towards resolving the shortage.
Separately, Horizon is planning to bring on an additional drug product manufacturer to help maintain adequate product inventory. However, this takes some lead time, as there is a process to obtain regulatory approvals for a new manufacturer.6. How long is this supply disruption expected to continue?
Horizon is working closely with the FDA to expedite the review of the supplement, which is an important step towards resolving the shortage. While we are hopeful the disruption in supply will end as soon as possible, we continue to anticipate the disruption could last through the first quarter of 2021.7. How has Horizon managed distribution of remaining TEPEZZA supply?
Horizon encourages sites of care (e.g., infusion centers, hospitals, etc.) to prioritize remaining product for those who already started treatment. Horizon suggests that each site of care continue treating patients as scheduled, until they no longer have any remaining medicine. Sites of care will run out of medicine at different times, depending on how much they have in stock and how many patients they have scheduled. Once a site of care runs out of medicine, they will not be able to order more for their patients until this temporary disruption in supply has been resolved. The TEPEZZA supply disruption could last through the first quarter of 2021.8. Were certain sites of care able to order mass shipments?
In an effort to evenly distribute remaining medicine across the hundreds of sites of care that administer TEPEZZA, Horizon has closely monitored orders being placed by the sites of care to help prevent any of the sites from receiving more medicine than they typically order.9. How do I know if my next treatment will continue as scheduled?
You may contact your site of care or your doctor to determine whether your next treatment will continue as scheduled. You can also talk with your Horizon Patient Access Manager (PAM) for support.10. What should I do if I have started therapy with TEPEZZA and have not completed all eight infusions?
Patients who have already started therapy with TEPEZZA may speak with their doctor about how to manage their care during this disruption. Of note, your doctor will not be able to answer questions about TEPEZZA supply, but he or she can discuss other potential ways to manage your TED during this supply disruption.11. What should I do if my doctor decided to start me on TEPEZZA, but I have yet to start therapy?
Patients who are waiting to begin therapy with TEPEZZA can speak with their doctor about how to manage their care during this disruption. Of note, your doctor will not be able to answer questions about TEPEZZA supply, but he or she can discuss other potential ways to manage your TED during this supply disruption.12. How can patients who have started or are waiting to start TEPEZZA therapy get in touch with Horizon?
You can contact your Horizon Patient Access Manager (PAM) by calling 1-833-469-8331 Monday-Friday, 8 a.m. to 8 p.m. EST. PAMs are trained professionals who understand your condition and what you may be going through. They can provide ongoing updates regarding the status of the short-term supply disruption and help answer questions that you may have.13. How will I know when TEPEZZA is available again?
You can follow the TEPEZZA Facebook and Instagram pages to get ongoing updates on the status of the short-term disruption in supply. You can also stay in contact with your Horizon Patient Access Manager (PAM).14. What is TEPEZZA?
TEPEZZA is the first and only medicine FDA-approved to treat TED. Unlike other medicines you and your doctor may have tried, TEPEZZA treats the cause of TED. When you have TED, a switch behind your eye, called a receptor, is turned on that causes redness and swelling. This can also make your eyes bulge. TEPEZZA is the only medicine that blocks this receptor to treat TED at its source. Learn more at www.TEPEZZA.com.15. In what form is TEPEZZA made available?
TEPEZZA is an IV (intravenous) treatment given once every three weeks for a total of eight treatments. This means it is delivered through a needle that is placed in your arm. The first and second treatments will last about 90 minutes. The remaining six treatments will take about 60 minutes each, but could be longer depending on how you respond to the medicine.16. What is Thyroid Eye Disease?
Thyroid Eye Disease (TED) is a vision-threatening autoimmune disease that often occurs in people living with Graves’ disease; however, it is a different disease that must be managed separately. Common symptoms of TED include double vision, bulging eyes, dry eyes, eye pain, eyelid redness and swelling, teary eyes, light sensitivity and vision changes.17. Is there a way for me to voice my concern about this disruption in the availability of TEPEZZA?
If you have concerns or would like to share information about your experience, there are patient advocacy organizations that can provide support:
- Prevent Blindness: (800) 331-2020 or email@example.com
- American Autoimmune Related Diseases Association (AARDA): firstname.lastname@example.org
- Lupus and Allied Diseases Association (LADA): email@example.com
- Vision Health Advocacy Coalition (VHAC): firstname.lastname@example.org
You can also phone or send an email to the FDA Office of the Ombudsman: (301) 796-8530 or email@example.com.
- High blood pressure
- Fast heartbeat
- Redness of the face/Feeling hot
- Difficulty breathing
- Muscle pain
- Have inflammatory bowel disease (Crohn’s disease or ulcerative colitis).
- Are currently being treated for diabetes, have been diagnosed with diabetes, or know your blood sugar is high.
- Are pregnant or plan to become pregnant. TEPEZZA may harm your unborn baby. Tell your doctor if you become pregnant or suspect you are pregnant during treatment with TEPEZZA.
- Women who are able to become pregnant should use an effective form of birth control (contraception) prior to starting treatment, during treatment and for at least 6 months after the final dose of TEPEZZA.
- Are breastfeeding or plan to breastfeed. It is not known if TEPEZZA passes into your breast milk. Talk to your doctor about the best ways to feed your baby during treatment with TEPEZZA.
- Tell your doctor about all the medicines you take, including prescription and over the counter medicines, vitamins, dietary and herbal supplements. Know the medicines you take. Keep a list of them to show your doctor and pharmacist when you get a new medicine.